Acquiring Company
Alkermes
Acquired Company
Avadel
Ireland
United StatesManufacturingBiotechnologyHealth CareBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
In February 2026, Alkermes plc completed the acquisition of Avadel Pharmaceuticals. This acquisition adds LUMRYZ to Alkermes' portfolio and enhances its commercial capabilities in treating narcolepsy. The move reflects Alkermes' strategic focus on expanding its therapeutic offerings in neuroscience.
Quick answer
Alkermes is acquiring Avadel, announced February 25, 2026. Alkermes is based in Ireland.
- How much did Alkermes pay for Avadel?
- The deal value was not disclosed.
- What does Alkermes do?
- Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.
- Where are Alkermes and Avadel based?
- Alkermes is based in Ireland. Avadel is based in United States.
- Who are the decision-makers at Alkermes?
- Fundz holds 3 contacts at Alkermes. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Aurinia acquires Kezar Life Sciences for $6.955/share (March 30, 2026)
- GSK to acquire 35Pharma for HS235 development (February 25, 2026)
- Servier Pharmaceuticals to acquire Day One Biopharma (March 11, 2026)
- Kopran Limited to merge with Kopran Laboratories Limited (February 27, 2026)
- Garda Therapeutics to acquire Assertio for $125.1M, $125M (April 8, 2026)
Who to call at Alkermes, and when
When Alkermes changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alkermes raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alkermes, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alkermes. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alkermes makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Avadel?
Avadel was acquired by Alkermes, based in Ireland. The deal was reported on February 25, 2026. Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. Alkermes is publicly traded (ALKS) and operates in Manufacturing.
When did Alkermes acquire Avadel?
Alkermes's acquisition of Avadel was reported on February 25, 2026. In February 2026, Alkermes plc completed the acquisition of Avadel Pharmaceuticals. This acquisition adds LUMRYZ to Alkermes' portfolio and enhances its commercial capabilities in treating narcolepsy. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Avadel do?
Avadel pharmaceuticals is transforming medicines to address the problems patients and healthcare professionals face with current treatment options for narcolepsy. It is privately held, operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.